Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1978 Jul;21(1):59–63. doi: 10.1128/iai.21.1.59-63.1978

Intraintestinal toxin in infant mice challenged intragastrically with Clostridium botulinum spores.

H Sugiyama, D C Mills
PMCID: PMC421957  PMID: 361570

Abstract

Conventionally raised suckling mice were injected intragastrically with 10(5) spores of a Clostridium botulinum type A culture. Botulism was not observed, but 80% or more of mice challenged when 8 to 11 days old had botulinum toxin in the large intestine 3 days later. Mice younger than 7 days or older than 15 days were resistant to the challenge. When in vivo toxin production was started by spores given to 9-day-old mice, toxin was present in the intestine at 1 through 7 days postchallenge but with greatest consistency between 1 and 4 days. Total toxin in an intestine ranged up to 1,920 50% lethal doses as titrated intraperitoneally in adult mice. The dose infecting 50% of a group of 9-day-old mice was 700 (95% confidence limits of 170 to 3,000) spores per animal. Toxin was formed in the lumen of the large intestine; it was not associated with the ileum. Injection of 10(5) spores intraperitoneally into 9-day-old mice resulted in toxin production in the large intestines of 30% of the test animals.

Full text

PDF
59

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnon S. S., Midura T. F., Clay S. A., Wood R. M., Chin J. Infant botulism. Epidemiological, clinical, and laboratory aspects. JAMA. 1977 May 2;237(18):1946–1951. doi: 10.1001/jama.237.18.1946. [DOI] [PubMed] [Google Scholar]
  2. Bott T. L., Johnson J., Jr, Foster E. M., Sugiyama H. Possible origin of the high incidence of Clostridium botulinum type E in an inland bay (Green Bay of Lake Michigan). J Bacteriol. 1968 May;95(5):1542–1547. doi: 10.1128/jb.95.5.1542-1547.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. MAY A. J., WHALER B. C. The absorption of Clostridium botulinum type A toxin from the alimentary canal. Br J Exp Pathol. 1958 Jun;39(3):307–316. [PMC free article] [PubMed] [Google Scholar]
  4. Midura T. F., Arnon S. S. Infant botulism. Identification of Clostridium botulinum and its toxins in faeces. Lancet. 1976 Oct 30;2(7992):934–936. doi: 10.1016/s0140-6736(76)90894-1. [DOI] [PubMed] [Google Scholar]
  5. SHVEDOV L. M. O neitralizatsii enteral'no vvedennoi antisyvorotkoi toksina, obrazuiushchegosia v pishchevaritel'nom trakte pri eksperimental'noi botulinovoi toksikoinfektsii tipa A. Zh Mikrobiol Epidemiol Immunobiol. 1959 Jan;30(1):72–77. [PubMed] [Google Scholar]
  6. Savage D. C. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 1977;31:107–133. doi: 10.1146/annurev.mi.31.100177.000543. [DOI] [PubMed] [Google Scholar]
  7. Sugii S., Ohishi I., Sakaguchi G. Intestinal absorption of botulinum toxins of different molecular sizes in rats. Infect Immun. 1977 Sep;17(3):491–496. doi: 10.1128/iai.17.3.491-496.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sugiyama H., Yang K. H. Growth potential of Clostridium botulinum in fresh mushrooms packaged in semipermeable plastic film. Appl Microbiol. 1975 Dec;30(6):964–969. doi: 10.1128/am.30.6.964-969.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Suzuki J. B., Booth R. R., Grecz N. Pathogenesis of Clostridium botulinum type A: release of toxin from C. botulinum spores in vitro by leucocytes. Res Commun Chem Pathol Pharmacol. 1970 Sep;1(5):691–711. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES